FWM
GHDX

Filbrandt Wealth Management’s Genomic Health, Inc. GHDX Stock Holding History

Filbrandt Wealth Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15
Closed -$1K – 484
2020
Q1 		$1K Buy
+15
New +$1K ﹤0.01% 245

Filbrandt Wealth Management's GHDX Position: Q2 2020 in Review

Filbrandt Wealth Management sold out of Genomic Health, Inc. (GHDX) in Q2 2020, closing a stake of 15 shares — an estimated $1K sold.

Filbrandt Wealth Management first reported a position in GHDX in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 0 funds tracked by Wall St. Rank hold GHDX as of Q2 2020.

  • Filbrandt Wealth Management reported no remaining Genomic Health, Inc. position as of Q2 2020 after selling out during the quarter.
  • Filbrandt Wealth Management sold 15 Genomic Health, Inc. shares in Q2 2020, an estimated $1K.
  • Filbrandt Wealth Management first reported a position in Genomic Health, Inc. in Q1 2020 and held it in 1 quarter.
  • Filbrandt Wealth Management's Genomic Health, Inc. position peaked at $1K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2020.

Based on Filbrandt Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.